1030 related articles for article (PubMed ID: 17694093)
61. Histone deacetylase inhibitors.
Monneret C
Eur J Med Chem; 2005 Jan; 40(1):1-13. PubMed ID: 15642405
[TBL] [Abstract][Full Text] [Related]
62. Aminosuberoyl hydroxamic acids (ASHAs): a potent new class of HDAC inhibitors.
Belvedere S; Witter DJ; Yan J; Secrist JP; Richon V; Miller TA
Bioorg Med Chem Lett; 2007 Jul; 17(14):3969-71. PubMed ID: 17507219
[TBL] [Abstract][Full Text] [Related]
63. Histone deacetylase inhibitors cooperate with IFN-gamma to restore caspase-8 expression and overcome TRAIL resistance in cancers with silencing of caspase-8.
Häcker S; Dittrich A; Mohr A; Schweitzer T; Rutkowski S; Krauss J; Debatin KM; Fulda S
Oncogene; 2009 Sep; 28(35):3097-110. PubMed ID: 19597472
[TBL] [Abstract][Full Text] [Related]
64. Modulation of cellular radiation responses by histone deacetylase inhibitors.
Karagiannis TC; El-Osta A
Oncogene; 2006 Jun; 25(28):3885-93. PubMed ID: 16462761
[TBL] [Abstract][Full Text] [Related]
65. Mechanisms of resistance to histone deacetylase inhibitors and their therapeutic implications.
Fantin VR; Richon VM
Clin Cancer Res; 2007 Dec; 13(24):7237-42. PubMed ID: 18094401
[TBL] [Abstract][Full Text] [Related]
66. HDACi--targets beyond chromatin.
Buchwald M; Krämer OH; Heinzel T
Cancer Lett; 2009 Aug; 280(2):160-7. PubMed ID: 19342155
[TBL] [Abstract][Full Text] [Related]
67. Histone deacetylase inhibitors: a novel target of anticancer therapy (review).
Kouraklis G; Theocharis S
Oncol Rep; 2006 Feb; 15(2):489-94. PubMed ID: 16391874
[TBL] [Abstract][Full Text] [Related]
68. Isoform-specific histone deacetylase inhibitors: the next step?
Balasubramanian S; Verner E; Buggy JJ
Cancer Lett; 2009 Aug; 280(2):211-21. PubMed ID: 19289255
[TBL] [Abstract][Full Text] [Related]
69. Identification of (1H)-pyrroles as histone deacetylase inhibitors with antitumoral activity.
Zubia A; Ropero S; Otaegui D; Ballestar E; Fraga MF; Boix-Chornet M; Berdasco M; Martinez A; Coll-Mulet L; Gil J; Cossío FP; Esteller M
Oncogene; 2009 Mar; 28(11):1477-84. PubMed ID: 19169274
[TBL] [Abstract][Full Text] [Related]
70. Histone deacetylase inhibitors: mechanism of action and therapeutic use in cancer.
Martínez-Iglesias O; Ruiz-Llorente L; Sánchez-Martínez R; García L; Zambrano A; Aranda A
Clin Transl Oncol; 2008 Jul; 10(7):395-8. PubMed ID: 18628067
[TBL] [Abstract][Full Text] [Related]
71. Targeting histone deacetylases for the treatment of cancer and inflammatory diseases.
Huang L
J Cell Physiol; 2006 Dec; 209(3):611-6. PubMed ID: 17001696
[TBL] [Abstract][Full Text] [Related]
72. Mechanisms of resistance to histone deacetylase inhibitors.
Lee JH; Choy ML; Marks PA
Adv Cancer Res; 2012; 116():39-86. PubMed ID: 23088868
[TBL] [Abstract][Full Text] [Related]
73. Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer.
Minucci S; Pelicci PG
Nat Rev Cancer; 2006 Jan; 6(1):38-51. PubMed ID: 16397526
[TBL] [Abstract][Full Text] [Related]
74. Mass spectrometry in epigenetic research.
Beck HC
Methods Mol Biol; 2010; 593():263-82. PubMed ID: 19957154
[TBL] [Abstract][Full Text] [Related]
75. Expression and functional characterization of recombinant human HDAC1 and HDAC3.
Li J; Staver MJ; Curtin ML; Holms JH; Frey RR; Edalji R; Smith R; Michaelides MR; Davidsen SK; Glaser KB
Life Sci; 2004 Apr; 74(22):2693-705. PubMed ID: 15043985
[TBL] [Abstract][Full Text] [Related]
76. Regulation of histone deacetylase activities.
Sengupta N; Seto E
J Cell Biochem; 2004 Sep; 93(1):57-67. PubMed ID: 15352162
[TBL] [Abstract][Full Text] [Related]
77. Histone deacetylase inhibitors in cancer therapy.
Fouladi M
Cancer Invest; 2006; 24(5):521-7. PubMed ID: 16939962
[No Abstract] [Full Text] [Related]
78. The potential of histone deacetylase inhibitors in lung cancer.
Aparicio A
Clin Lung Cancer; 2006 Mar; 7(5):309-12. PubMed ID: 16640801
[TBL] [Abstract][Full Text] [Related]
79. Histone deacetylase inhibitors in the treatment of cancer: overview and perspectives.
Giannini G; Cabri W; Fattorusso C; Rodriquez M
Future Med Chem; 2012 Jul; 4(11):1439-60. PubMed ID: 22857533
[TBL] [Abstract][Full Text] [Related]
80. Strategies in developing promising histone deacetylase inhibitors.
Zhang L; Fang H; Xu W
Med Res Rev; 2010 Jul; 30(4):585-602. PubMed ID: 19634125
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
